ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
801 | 50.44998 | 1 |
female
| 1 | 6 | 6 |
Coma
|
Coma
| 2 | null | null | 55 | 28,491 | null | null | 24 |
white
| 26.199219 | 50 | 0.520996 | 0.450989 | 1 | 1 | 0 |
no
| 0.05 | 0.000125 |
dnr after sadm
| 3 | 63 | 28 | 160 | 30 | 40.89844 | 336.625 | null | 0.899902 | 0.799927 | 140 | 7.489258 | null | null | null | null | null |
<2 mo. follow-up
| 2.632813 |
802 | 72 | 1 |
female
| 0 | 13 | 612 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 12 |
under $11k
| 0 | 40,390 | 21,526 | null | 12.5 |
black
| 15.5 | 15 | 0.885986 | 0.809937 | 1 | 0 | 0 |
no
| 0.75 | 0.7 |
no dnr
| 13 | 83 | 8.898438 | 100 | 24 | 37 | 404.75 | null | 0.599976 | 0.899902 | 138 | 7.459961 | null | null | null | null | null | null | 2.584961 |
803 | 65.92999 | 0 |
female
| 0 | 16 | 1,336 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 12 | null | 0 | 60,355 | 30,505.6719 | null | 12.333328 |
white
| 21 | 29 | 0.809937 | 0.692993 | 1 | 1 | 0 |
yes
| 0.99 | 0.98 |
no dnr
| 16 | 63 | 7.099609 | 50 | 20 | 36.5 | null | null | null | 2.099609 | 140 | null | null | null | null | 2 | null | null | 1.839 |
804 | 69.77997 | 0 |
male
| 0 | 21 | 1,333 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 16 |
$25-$50k
| 0 | 117,036 | 59,274 | null | 22 |
white
| 22 | 27 | 0.822998 | 0.711914 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 21 | 57 | 8.699219 | 50 | 24 | 37 | 486.625 | 3.199707 | null | 1.299805 | 133 | 7.489258 | null | null | null | null | null |
no(M2 and SIP pres)
| 2.812988 |
805 | 59.211 | 1 |
female
| 1 | 4 | 4 |
Lung Cancer
|
Cancer
| 3 | 14 |
>$50k
| 41 | 8,126 | 3,478.2188 | null | 20 |
white
| 18.898438 | 21 | 0.504883 | 0.18399 | 1 | 0 | 0 |
metastatic
| 0.01 | 0.000001 |
dnr after sadm
| 1 | 60 | 1.299805 | 90 | 20 | 37.19531 | null | null | null | 1.199951 | 127 | null | null | null | null | null | 6 |
<2 mo. follow-up
| 6 |
806 | 32.27698 | 1 |
female
| 1 | 8 | 8 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 16 |
>$50k
| 0 | 175,267 | 79,371.5625 | null | 23.5 |
white
| 29.398438 | 35 | 0.517944 | 0.401978 | 19 | 0 | 0 |
yes
| 0.2 | 0.1 |
dnr after sadm
| 5 | 117 | 11.5 | 120 | 40 | 36 | 171.40625 | 2.399902 | 1.5 | 1.199951 | 134 | 7.419922 | null | null | null | null | null |
<2 mo. follow-up
| 2.416504 |
807 | 47.63898 | 1 |
female
| 0 | 9 | 723 |
Lung Cancer
|
Cancer
| 1 | 13 |
under $11k
| 0 | 13,877 | 7,902.1992 | null | 8 |
white
| 14.699219 | 16 | 0.785889 | 0.549927 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.5 |
no dnr
| 9 | 77 | 1.199951 | 80 | 20 | 36.59375 | null | null | null | 0.799927 | 136 | null | null | null | null | 0 | null | null | 0.4948 |
808 | 74.26398 | 1 |
male
| 0 | 10 | 41 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 14 |
>$50k
| 0 | 35,636 | 17,422.5 | null | 18 |
white
| 31.5 | 37 | 0.628906 | 0.445984 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 10 | 40 | 6.799805 | 65 | 20 | 36.44531 | null | null | null | 1.5 | 131 | null | null | null | null | 1 | 0 |
<2 mo. follow-up
| 0 |
809 | 71.29895 | 1 |
male
| 1 | 6 | 6 |
Coma
|
Coma
| 0 | 14 | null | 94 | 37,330 | 22,028.1719 | null | 29 |
white
| 21 | 23 | 0.257996 | 0.190979 | 1 | 0 | 0 |
no
| 0.1 | 0.001 |
dnr after sadm
| 3 | 62 | 21.699219 | 115 | 10 | 38.89844 | 317.125 | null | 0.5 | 1.099854 | 132 | 7.509766 | null | null | null | null | null |
<2 mo. follow-up
| 2.59082 |
810 | 78.05096 | 0 |
male
| 0 | 26 | 1,328 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 | null | 26 | 167,412 | 81,337.0625 | null | 28 |
white
| 29.5 | 44 | 0.347961 | 0.230988 | 10 | 0 | 0 |
yes
| null | null |
no dnr
| 26 | 52 | 8.398438 | 110 | 10 | 38.5 | 98.75 | null | null | 1.399902 | 141 | 7.529297 | null | null | null | null | 0 |
no(M2 and SIP pres)
| 0 |
811 | 82.88599 | 0 |
male
| 0 | 3 | 1,326 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 14 |
$11-$25k
| 0 | 8,568 | 4,712.4023 | null | 8 |
white
| 15.5 | 17 | 0.822998 | 0.711914 | 1 | 0 | 0 |
yes
| 0.65 | 0.5 |
no dnr
| 3 | 85 | 10.099609 | 65 | 16 | 36.5 | null | null | null | 1.099854 | 139 | null | null | null | null | 0 | null |
no(M2 and SIP pres)
| 0.4948 |
812 | 55.37 | 0 |
male
| 0 | 7 | 1,326 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 16 |
$25-$50k
| 0 | 30,070 | 16,821.3906 | null | 13.5 |
white
| 22 | 31 | 0.86792 | 0.780884 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 7 | 80 | 6.799805 | 100 | 28 | 35.69531 | null | 4 | 4.099609 | 1.299805 | 132 | null | null | null | null | 1 | 4 |
no(M2 and SIP pres)
| 4 |
813 | 63.53198 | 0 |
male
| 0 | 19 | 1,323 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 26 | 188,077 | 97,198.875 | null | 16 |
other
| 20.796875 | 34 | 0.719971 | 0.633911 | 20 | 1 | 0 |
no
| null | null |
no dnr
| 19 | 138 | 6.799805 | 100 | 28 | 36.39844 | 254.28125 | null | null | 0.599976 | 136 | 7.489258 | null | null | null | null | null | null | 2.53125 |
814 | 72.32599 | 1 |
male
| 0 | 8 | 71 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3 | 19 |
$25-$50k
| 9 | 21,341 | 13,080.7344 | null | 7 |
white
| 22.699219 | 43 | 0.61792 | 0.431946 | 1 | 1 | 0 |
no
| 0.9 | 0.9 |
no dnr
| 8 | 71 | 4.599609 | 86 | 16 | 36.39844 | 423.75 | 3.299805 | 4 | 2.099609 | 133 | 7.489258 | null | null | null | null | null |
adl>=4 (>=5 if sur)
| 3.848633 |
815 | 50.64499 | 1 |
male
| 0 | 4 | 8 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1 | 14 |
$11-$25k
| 0 | 27,047 | 14,579.1094 | null | 10 |
white
| 19.597656 | 15 | 0.803955 | 0.68396 | 7 | 0 | 0 |
no
| 0.5 | 0.25 |
no dnr
| 4 | 77 | 10.898438 | 72 | 22 | 36.19531 | null | null | null | 1.299805 | 130 | null | null | null | null | 1 | null |
<2 mo. follow-up
| 1.1669 |
816 | 44.37 | 1 |
female
| 1 | 8 | 8 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3 | 11 |
$11-$25k
| 55 | 88,231 | 43,843.0312 | null | 35 |
white
| 39.695313 | 69 | 0.202972 | 0.061996 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 8 | 102 | 38 | 70 | 32 | 36.39844 | 243 | 2.899902 | 42 | 6.799805 | 147 | 7.229492 | null | null | null | null | 1 |
<2 mo. follow-up
| 1 |
817 | 52.75598 | 1 |
female
| 1 | 3 | 3 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 100 | 25,511 | 14,848.5469 | null | 25 |
white
| 48.898438 | 73 | 0.004999 | 0.001 | 1 | 1 | 0 |
no
| 0.1 | 0.001 |
no dnr
| 3 | 38 | 15.398438 | 0 | 0 | 38.19531 | 186 | null | null | 0.799927 | 156 | 7.069336 | null | null | null | null | null |
<2 mo. follow-up
| 3.945313 |
818 | 63.27197 | 1 |
male
| 0 | 8 | 60 |
Lung Cancer
|
Cancer
| 1 | null |
under $11k
| 0 | 11,532 | 6,581.8242 | null | 7.5 |
white
| 17.597656 | 15 | 0.699951 | 0.412964 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.512 |
dnr after sadm
| 4 | 101 | 8.199219 | 78 | 20 | 36 | null | null | null | 0.899902 | 131 | null | null | null | null | 1 | 5 | null | 5 |
819 | 68.20294 | 1 |
female
| 0 | 44 | 267 |
Colon Cancer
|
Cancer
| 2 | 14 |
under $11k
| 0 | 133,944 | 62,226.3438 | null | 22 |
white
| 21 | 21 | 0.747925 | 0.487 | 1 | 1 | 0 |
metastatic
| 0.95 | 0.8 |
no dnr
| 44 | 113 | 15.599609 | 108 | 28 | 37.19531 | null | null | 1.299805 | 0.799927 | 137 | null | null | null | null | 0 | 0 |
no(M2 and SIP pres)
| 0 |
820 | 72.12598 | 0 |
male
| 0 | 8 | 1,318 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 41 | 127,395 | null | null | 25 |
white
| 25.796875 | 45 | 0.520996 | 0.404968 | 7 | 0 | 0 |
no
| null | null |
no dnr
| 8 | 113 | 13.298828 | 140 | 37 | 38 | 181.625 | null | null | 1 | 147 | 7.479492 | null | null | null | null | null | null | 4.060547 |
821 | 71.11298 | 1 |
female
| 1 | 4 | 4 |
Lung Cancer
|
Cancer
| 2 | 11 |
under $11k
| 41 | 9,606 | 4,738.4609 | null | 15 |
black
| 43.796875 | 65 | 0.003 | 0 | 1 | 1 | 0 |
metastatic
| 0.25 | 0.15 |
dnr after sadm
| 2 | 33 | 21.097656 | 124 | 32 | 36.79688 | 403.3125 | null | null | 2.099609 | 144 | 7.429688 | null | null | null | null | null |
<2 mo. follow-up
| 3.733887 |
822 | 63.836 | 0 |
female
| 0 | 9 | 1,315 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 |
>$50k
| 0 | 31,055 | 15,986.5625 | null | 15.5 |
white
| 22.796875 | 24 | 0.833984 | 0.728882 | 1 | 0 | 0 |
no
| 0.8 | 0.65 |
no dnr
| 9 | 70 | 14.798828 | 60 | 20 | 35.69531 | 186.65625 | null | null | 1.399902 | 136 | 7.299805 | null | null | null | 1 | null |
no(M2 and SIP pres)
| 1.1669 |
823 | 52.38599 | 0 |
male
| 0 | 12 | 1,315 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 14 | null | 0 | 140,565 | 64,369.125 | null | 26.5 |
white
| 36.296875 | 42 | 0.283997 | 0.174988 | 15 | 0 | 0 |
yes
| null | null |
no dnr
| 12 | 65 | 1 | 100 | 26 | 39.19531 | 122.4375 | null | 3.699707 | 0.799927 | 133 | 7.5 | null | null | null | null | null |
no(M2 and SIP pres)
| 2.367676 |
824 | 86.04199 | 1 |
male
| 1 | 21 | 21 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
under $11k
| 37 | 205,980 | 99,348.6875 | null | 36 |
white
| 26.796875 | 50 | 0.432983 | 0.312988 | 5 | 0 | 0 |
no
| null | null |
dnr after sadm
| 12 | 115 | 0.599976 | 110 | 12 | 36.89844 | 231.40625 | null | null | 1.199951 | 144 | 7.5 | null | null | null | null | 0 |
<2 mo. follow-up
| 0 |
825 | 80.646 | 1 |
female
| 0 | 16 | 262 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 13 |
under $11k
| 0 | 34,235 | 21,265.7344 | null | 15 |
white
| 16.398438 | 22 | 0.85498 | 0.760986 | 1 | 1 | 0 |
no
| null | null |
no dnr
| 16 | 80 | 7.5 | 60 | 22 | 36.39844 | 328.5625 | null | null | 1.299805 | 142 | 7.489258 | null | null | null | null | null |
no(M2 and SIP pres)
| 3.243652 |
826 | 70.034 | 1 |
male
| 0 | 3 | 208 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 16 | null | 0 | 6,528 | 4,963.5117 | null | 8 |
white
| 21.296875 | 39 | 0.830933 | 0.724976 | 1 | 1 | 0 |
no
| null | null |
no dnr
| 3 | 65 | 8.898438 | 85 | 18 | 35.89844 | null | null | null | 2.599609 | 136 | null | null | null | null | 2 | null |
no(M2 and SIP pres)
| 1.839 |
827 | 65.99896 | 0 |
female
| 0 | 27 | 1,306 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2 | 11 | null | 0 | 53,190 | 27,477.9375 | null | 14 |
white
| 18.796875 | 28 | 0.775879 | 0.641968 | 1 | 0 | 0 |
no
| 0.5 | 0.1 |
no dnr
| 27 | 75 | 6.899414 | 96 | 24 | 38.19531 | null | 2.299805 | 2.699707 | 0.699951 | 131 | null | null | null | null | 5 | 5 |
SIP>=30
| 5 |
828 | 70.59296 | 1 |
male
| 0 | 6 | 135 |
Lung Cancer
|
Cancer
| 2 | 12 | null | 0 | 17,079 | 11,626.0938 | null | 8 |
asian
| 34.296875 | 45 | 0.22699 | 0.024998 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.6 |
no dnr
| 6 | 78 | 0.5 | 100 | 16 | 36.79688 | null | 2.5 | 5.199219 | 0.699951 | 132 | null | null | null | null | null | 4 |
no(M2 and SIP pres)
| 4 |
829 | 49.99597 | 1 |
female
| 1 | 87 | 87 |
Coma
|
Coma
| 0 | 14 |
under $11k
| 44 | 712,554 | null | null | 36 |
white
| 38.296875 | 60 | 0.125 | 0.078995 | 21 | 0 | 0 |
no
| null | null |
dnr after sadm
| 86 | 48 | 17.296875 | 140 | 44 | 39.79688 | 220 | null | 4.5 | 1.399902 | 151 | 7.429688 | null | null | null | null | 6 |
adl>=4 (>=5 if sur)
| 6 |
830 | 62.89899 | 0 |
female
| 0 | 6 | 1,305 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 16 |
$11-$25k
| 0 | 12,826 | 8,660.6875 | null | 12 |
black
| 19.699219 | 26 | 0.870972 | 0.785889 | 1 | 1 | 0 |
no
| null | null |
no dnr
| 6 | 75 | 5.699219 | 90 | 20 | 37 | 304.75 | null | null | 1.199951 | 126 | 7.439453 | null | null | null | null | null |
no(M2 and SIP pres)
| 2.188477 |
831 | 55.87698 | 1 |
female
| 0 | 14 | 66 |
COPD
|
COPD/CHF/Cirrhosis
| 5 | null | null | 26 | 55,987 | 93.8955 | null | 15.666664 |
white
| 19.898438 | 31 | 0.822998 | 0.712891 | 1 | 1 | 0 |
yes
| null | null |
dnr after sadm
| 2 | 63 | 11.798828 | 95 | 10 | 37.69531 | 187.5 | 3.699707 | 0.5 | 2 | 137 | 7.299805 | null | null | null | null | null | null | 3.985352 |
832 | 42.237 | 1 |
female
| 0 | 9 | 14 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 16 |
$25-$50k
| 0 | 41,885 | 22,365.5781 | null | 16 |
white
| 26.796875 | 29 | 0.805908 | 0.740967 | 6 | 0 | 0 |
no
| 0.15 | 0.05 |
no dnr
| 9 | 100 | 7.299805 | 82 | 24 | 35.19531 | 136.71875 | null | 5.199219 | 1.199951 | 137 | 7.439453 | null | null | null | 0 | null |
<2 mo. follow-up
| 0.4948 |
833 | 49.60999 | 0 |
female
| 0 | 4 | 1,084 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1 | 14 |
>$50k
| 0 | 5,215 | 3,137.3457 | 3,357.18945 | 8 |
white
| 15.199219 | 34 | 0.889893 | 0.815918 | 1 | 0 | 0 |
no
| 0.9 | 0.74 |
no dnr
| 4 | 71 | 4.899414 | 64 | 22 | 36.39844 | null | 2.299805 | 1.5 | 1.099854 | 139 | null | 104 | 19 | 360 | 1 | 1 |
no(M2 and SIP pres)
| 1 |
834 | 78.43695 | 1 |
female
| 0 | 14 | 86 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 12 | null | 9 | 34,499 | 18,041.7344 | 13,913.4531 | 14.333328 |
white
| 23.898438 | 27 | 0.695923 | 0.531982 | 1 | 0 | 0 |
no
| 0.4 | 0.2 |
dnr after sadm
| 2 | 63 | 14.798828 | 72 | 24 | 37.59375 | 157.125 | 3 | 0.399963 | 1.799805 | 140 | 7.339844 | 74 | 35 | 2,600 | null | 3 |
adl>=4 (>=5 if sur)
| 3 |
835 | 55.98599 | 1 |
male
| 1 | 27 | 27 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 18 |
>$50k
| 0 | 90,756 | 45,550.0625 | 57,981.3125 | 21.25 |
white
| 22.296875 | 25 | 0.862915 | 0.772949 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 27 | 80 | 8.5 | 74 | 20 | 35.59375 | 409.5 | 3.599609 | 1.699951 | 1.599854 | 128 | 7.5 | 141 | 31 | 1,875 | 0 | 0 |
<2 mo. follow-up
| 0 |
836 | 74.46698 | 1 |
female
| 1 | 16 | 16 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 |
$11-$25k
| 41 | 161,673 | 46,653.2188 | 57,038 | 37.666657 |
white
| 22 | 22 | 0.514893 | 0.397949 | 10 | 0 | 0 |
yes
| 0.75 | 0.75 |
dnr after sadm
| 15 | 118 | 9.599609 | 110 | 24 | 39.19531 | 280.9375 | 3.299805 | 0.299988 | 0.599976 | 130 | 7.549805 | 116 | 3 | 3,690 | null | 0 |
<2 mo. follow-up
| 0 |
837 | 44.90097 | 1 |
female
| 1 | 25 | 25 |
MOSF w/Malig
|
ARF/MOSF
| 4 | 14 |
>$50k
| 0 | 307,552 | 119,536.188 | 134,474.75 | 36.25 |
other
| 33.5 | 65 | 0.287964 | 0.177979 | 18 | 1 | 0 |
metastatic
| 0.75 | 0.5 |
dnr after sadm
| 23 | 62 | 16.898438 | 95 | 26 | 36.29688 | 125 | 3.399902 | 2.5 | 2.899902 | 144 | 7.479492 | 433 | 40 | 1,240 | null | 0 |
<2 mo. follow-up
| 0 |
838 | 44.383 | 1 |
male
| 0 | 29 | 109 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 20 |
>$50k
| 0 | 246,214 | 61,128.875 | 66,810.9375 | 30.5 |
white
| 21.296875 | 33 | 0.848999 | 0.797974 | 20 | 1 | 0 |
no
| 0.2 | 0.1 |
no dnr
| 29 | 65 | 7.099609 | 80 | 26 | 36.5 | 300 | null | 0.799927 | 2.699707 | 145 | 7.489258 | 139 | 29 | 5,040 | null | null | null | 2.456055 |
839 | 26.51299 | 0 |
female
| 0 | 13 | 1,079 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 17 |
under $11k
| 26 | 87,124 | 28,491.8594 | 88,260.25 | 29.5 |
hispanic
| 34.695313 | 47 | 0.643921 | 0.542969 | 6 | 0 | 0 |
no
| null | null |
no dnr
| 13 | 113 | 19 | 135 | 44 | 38.39844 | 95.375 | null | 2.5 | 0.699951 | 133 | 7.5 | 114 | 7 | 6,500 | null | 0 |
no(M2 and SIP pres)
| 0 |
840 | 70.90796 | 1 |
male
| 1 | 18 | 18 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 9 | 390,845 | 51,077.6875 | 54,144.125 | 36.666657 |
white
| 37.695313 | 71 | 0.29895 | 0.187988 | 32 | 0 | 0 |
no
| 0.01 | 0.01 |
dnr after sadm
| 1 | 50 | 26.199219 | 120 | 28 | 38.69531 | 392.5625 | null | 5.5 | 2.199707 | 133 | 7.509766 | 213 | 65 | 5,880 | null | null |
<2 mo. follow-up
| 3.464356 |
841 | 63.64697 | 1 |
male
| 0 | 23 | 157 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 16 | null | 0 | 142,625 | 60,269.375 | 205,850.25 | 42.333313 |
white
| 16.796875 | 37 | 0.861938 | 0.814941 | 1 | 0 | 0 |
yes
| 0.75 | 0.6 |
no dnr
| 23 | 65 | 7.099609 | 55 | 21 | 37.69531 | 237.125 | 2.199707 | 2.299805 | 0.799927 | 137 | 7.459961 | 215 | 12 | 5,605 | null | 6 |
adl>=4 (>=5 if sur)
| 6 |
842 | 72.54797 | 1 |
female
| 0 | 5 | 354 |
Colon Cancer
|
Cancer
| 0 | null | null | 0 | 10,862 | 5,092.5898 | 7,937.4375 | 19 |
asian
| 15.798828 | 12 | 0.819946 | 0.611938 | 1 | 0 | 0 |
metastatic
| 0.5 | 0.3 |
no dnr
| 5 | 69 | 5.199219 | 72 | 20 | 36.39844 | null | 3.299805 | 0.199982 | 1.099854 | 138 | null | null | 13 | 2,125 | null | null | null | 1.832031 |
843 | 81.24298 | 0 |
male
| 0 | 26 | 1,076 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 14 | null | 44 | 172,335 | 78,254 | 88,530.5 | 35.75 |
white
| 31 | 42 | 0.377991 | 0.259949 | 1 | 0 | 0 |
no
| 0.3 | 0.3 |
no dnr
| 26 | 60 | 14.5 | 110 | 12 | 38.69531 | 92 | 2.5 | 1.399902 | 1.399902 | 130 | 7.5 | 106 | 23 | 5,075 | null | 2 |
no(M2 and SIP pres)
| 2 |
844 | 34.59299 | 1 |
male
| 1 | 13 | 13 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 17 |
under $11k
| 0 | 118,073 | 45,941.9375 | 119,265.875 | 38 |
white
| 29.199219 | 33 | 0.527954 | 0.412964 | 2 | 0 | 0 |
metastatic
| 0.6 | 0.3 |
dnr after sadm
| 7 | 97 | 21.5 | 146 | 32 | 39 | 280.9375 | null | null | 0.599976 | 127 | 7.5 | 119 | 6 | 2,159 | null | 7 |
<2 mo. follow-up
| 7 |
845 | 61.39398 | 1 |
male
| 0 | 11 | 20 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 14 |
$11-$25k
| 0 | 54,893 | 23,850.4531 | 28,051.6875 | 31.5 |
white
| 23.5 | 25 | 0.832886 | 0.726929 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 11 | 75 | 9.798828 | 65 | 20 | 36 | null | null | 1.599854 | 1.799805 | 129 | null | 80 | 63 | 2,375 | null | 2 |
<2 mo. follow-up
| 2 |
846 | 76.05499 | 0 |
male
| 0 | 4 | 1,070 |
CHF
|
COPD/CHF/Cirrhosis
| 5 | 14 | null | 0 | 7,626 | 4,572.4883 | 4,176.71875 | 9 |
white
| 20 | 25 | 0.784912 | 0.654907 | 1 | 0 | 1 |
yes
| 0.6 | 0.5 |
no dnr
| 4 | 101 | 6.799805 | 114 | 20 | 36.79688 | null | null | 0.599976 | 1.699951 | 139 | null | 161 | 39 | 2,390 | 6 | null |
no(M2 and SIP pres)
| 4.527344 |
847 | 49.49197 | 0 |
female
| 0 | 26 | 1,067 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
>$50k
| 0 | 177,889 | 56,882.1562 | 159,476.75 | 30 |
white
| 31.5 | 43 | 0.689941 | 0.5979 | 7 | 0 | 0 |
no
| 0.85 | 0.85 |
no dnr
| 26 | 105 | 13 | 110 | 30 | 39.29688 | 105 | 4.5 | null | 0.599976 | 147 | 7.469727 | 105 | 25 | 1,480 | null | 7 |
no(M2 and SIP pres)
| 7 |
848 | 78.03699 | 1 |
male
| 0 | 15 | 74 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 |
$11-$25k
| 0 | 35,566 | 19,382.1406 | 14,667.875 | 20.666656 |
white
| 24.699219 | 41 | 0.689941 | 0.523926 | 1 | 0 | 0 |
yes
| 0.5 | 0.25 |
dnr after sadm
| 1 | 75 | 36.09375 | 70 | 22 | 36 | 414.25 | null | null | 2.5 | 135 | 7.489258 | 90 | 71 | 650 | 5 | null | null | 3.854981 |
849 | 54.02298 | 1 |
female
| 1 | 46 | 46 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 10 | null | 89 | 676,210 | 179,056.875 | 200,250.125 | 40.5 |
white
| 36.296875 | 77 | 0.084991 | 0.032997 | 39 | 0 | 0 |
no
| null | null |
no dnr
| 46 | 55 | 12.898438 | 115 | 46 | 39.19531 | 290 | 3.299805 | 4.599609 | 3.799805 | 143 | 7.439453 | 74 | 95 | 160 | null | 0 |
<2 mo. follow-up
| 0 |
850 | 85.10297 | 0 |
female
| 0 | 14 | 1,065 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 9 | 62,841 | 21,997.9062 | 25,121.2969 | 14.333328 |
white
| 29.796875 | 34 | 0.495972 | 0.377991 | 5 | 1 | 0 |
no
| 0.9 | 0.8 |
dnr before sadm
| -4 | 73 | 10.099609 | 105 | 24 | 38 | 83.32812 | null | null | 1.199951 | 128 | 7.469727 | 353 | 20 | 2,978 | 1 | 1 |
no(M2 and SIP pres)
| 1 |
851 | 52.02197 | 0 |
male
| 0 | 52 | 1,063 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5 | 16 |
$11-$25k
| 26 | 593,198 | 174,370.625 | 200,240.375 | 31.75 |
hispanic
| 24.898438 | 42 | 0.684937 | 0.591919 | 33 | 0 | 0 |
no
| null | null |
no dnr
| 52 | 108 | 3.799805 | 55 | 32 | 38.39844 | 418.3125 | null | 3.599609 | 1.5 | 145 | 7.419922 | 332 | 81 | 1,760 | null | 7 |
no(M2 and SIP pres)
| 7 |
852 | 86.62799 | 0 |
male
| 0 | 20 | 1,061 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 26 | 96,480 | 25,141.3281 | 110,968.812 | 25.333328 |
white
| 25.296875 | 27 | 0.501953 | 0.383972 | 9 | 0 | 0 |
no
| null | null |
no dnr
| 20 | 98 | 28.898438 | 75 | 36 | 36.39844 | 142 | null | null | 1 | 150 | 7.519531 | 357 | 16 | null | null | 0 | null | 0 |
853 | 58.95398 | 1 |
female
| 1 | 11 | 11 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | null | null | 0 | 298,234 | 39,437.875 | 49,378.625 | 34.5 |
white
| 32.398438 | 56 | 0.570923 | 0.459961 | 71 | 0 | 0 |
no
| 0.1 | 0.1 |
no dnr
| 11 | 135 | 5.599609 | 95 | 10 | 39.09375 | 170 | null | 18.898438 | 1.5 | 153 | 7.439453 | 182 | 76 | 1,880 | null | null |
<2 mo. follow-up
| 3.206543 |
854 | 57.69699 | 1 |
male
| 0 | 4 | 320 |
Lung Cancer
|
Cancer
| 1 | 16 |
>$50k
| 0 | 12,827 | 5,347.5469 | 5,639.44922 | 7 |
white
| 16.097656 | 10 | 0.741943 | 0.47699 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 4 | 112 | 11.699219 | 80 | 16 | 37 | null | 3.299805 | 0.299988 | 1 | 141 | null | 94 | 14 | 6,360 | 0 | null |
no(M2 and SIP pres)
| 0.494751 |
855 | 59.44397 | 1 |
male
| 1 | 18 | 18 |
Coma
|
Coma
| 1 | 24 |
>$50k
| 0 | 223,643 | 93,965.8125 | 154,506.25 | 54 |
white
| 20.5 | 33 | 0.784912 | 0.743896 | 1 | 1 | 0 |
no
| null | null |
dnr after sadm
| 17 | 142 | 19.296875 | 115 | 8 | 38.79688 | 317.75 | null | 1.899902 | 1.099854 | 144 | 7.509766 | 393 | 33 | 3,050 | null | 0 |
<2 mo. follow-up
| 0 |
856 | 37.74698 | 1 |
male
| 1 | 13 | 13 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 16 |
$25-$50k
| 89 | 577,381 | 99,014.5 | 111,047.625 | 57 |
white
| 35.695313 | 83 | 0.18399 | 0.095993 | 28 | 0 | 0 |
no
| 0 | 0 |
dnr after sadm
| 13 | 62 | 9.199219 | 145 | 12 | 37.89844 | 280 | 4.899414 | 32.695313 | 2.599609 | 138 | 7.489258 | 129 | 71 | 12 | null | 3 |
<2 mo. follow-up
| 3 |
857 | 52.99698 | 1 |
male
| 1 | 3 | 3 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 |
>$50k
| 100 | 174,687 | 14,567.3828 | 17,020.0156 | 47 |
white
| 43.398438 | 74 | 0.011999 | 0.002 | 8 | 0 | 0 |
no
| 0.5 | 0.5 |
dnr after sadm
| 3 | 42 | 6.799805 | 105 | 29 | 35.5 | 307.5 | null | 6.399414 | 8 | 145 | 7.389648 | 658 | 98 | 0 | null | null |
<2 mo. follow-up
| 3.782715 |
858 | 76.28497 | 0 |
male
| 0 | 35 | 1,060 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 |
>$50k
| 0 | 141,756 | 64,223.875 | 63,816.7188 | 31 |
white
| 34.195313 | 58 | 0.459961 | 0.340942 | 1 | 0 | 0 |
yes
| null | null |
no dnr
| 35 | 72 | 6.299805 | 180 | 10 | 36.79688 | 64 | 2 | null | 0.799927 | 129 | 7.5 | 165 | 26 | 3,450 | null | 1 |
adl>=4 (>=5 if sur)
| 1 |
859 | 57.53 | 0 |
female
| 0 | 53 | 1,059 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 12 |
$25-$50k
| 41 | 261,184 | 121,786.438 | 115,827.938 | 29 |
white
| 33.5 | 58 | 0.399963 | 0.280945 | 1 | 1 | 0 |
yes
| 0.5 | 0.7 |
no dnr
| 53 | 58 | 17.5 | 130 | 12 | 38.5 | 325.6875 | 2.599609 | 0.5 | 4.099609 | 125 | 7.429688 | 841 | 66 | 895 | null | 7 |
adl>=4 (>=5 if sur)
| 7 |
860 | 70.20398 | 1 |
male
| 0 | 4 | 245 |
Lung Cancer
|
Cancer
| 1 | 10 |
$25-$50k
| 0 | 10,586 | 3,956.8867 | 4,522.85938 | 13 |
white
| 13.798828 | 10 | 0.756958 | 0.500977 | 1 | 0 | 0 |
metastatic
| 1 | 0.5 |
no dnr
| 4 | 123 | null | 78 | 18 | 36.79688 | null | null | null | 0.899902 | 137 | null | null | 5 | 5,170 | 0 | 0 |
SIP>=30
| 0 |
861 | 66.04498 | 1 |
male
| 0 | 4 | 385 |
Lung Cancer
|
Cancer
| 1 | 13 |
>$50k
| 0 | 11,532 | 4,416.3945 | 4,909.53906 | 13 |
white
| 16.398438 | 12 | 0.717896 | 0.439941 | 1 | 0 | 0 |
metastatic
| 1 | 0.5 |
no dnr
| 4 | 79 | 11.5 | 80 | 16 | 36.79688 | null | null | null | 1.399902 | 135 | null | null | 15 | 5,250 | 1 | 0 |
no(M2 and SIP pres)
| 0 |
862 | 42.69397 | 0 |
male
| 0 | 11 | 1,058 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 0 | 76,504 | 28,285.4219 | 29,885.0625 | 37.5 |
white
| 28.699219 | 27 | 0.792969 | 0.724976 | 3 | 0 | 0 |
no
| 0.95 | 0.95 |
no dnr
| 11 | 103 | 2.399902 | 125 | 26 | 39.29688 | 286.625 | 2.5 | 0.5 | 1 | 130 | 7.449219 | 123 | 12 | 2,000 | null | null | null | 3.315918 |
863 | 44.23297 | 0 |
male
| 0 | 7 | 1,057 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 10 | null | 0 | 78,031 | 17,341.1094 | 19,316.0156 | 15 |
hispanic
| 25.796875 | 39 | 0.80896 | 0.745972 | 7 | 0 | 0 |
no
| 0.95 | 0.95 |
no dnr
| 7 | 72 | 19.199219 | 75 | 36 | 38.89844 | 136.71875 | 2.5 | 3.799805 | 1.299805 | 143 | 7.459961 | 101 | 26 | 4,005 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
864 | 49.892 | 1 |
male
| 1 | 7 | 7 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 |
under $11k
| 0 | 36,044 | 13,711.9844 | 16,086.1641 | 14.5 |
white
| 31.5 | 55 | 0.652954 | 0.553955 | 3 | 0 | 0 |
yes
| 0 | 0 |
no dnr
| 7 | 70 | 2.299805 | 125 | 35 | 37.89844 | null | null | null | 2.5 | 140 | null | null | 52 | 1,350 | null | 3 |
<2 mo. follow-up
| 3 |
865 | 20.523 | 1 |
male
| 0 | 52 | 66 |
MOSF w/Malig
|
ARF/MOSF
| 4 | null |
$11-$25k
| 0 | 784,726 | 180,566 | 189,590.375 | 34.25 |
other
| 34.5 | 57 | 0.370972 | 0.252991 | 88 | 1 | 0 |
yes
| 0.5 | 0.5 |
dnr after sadm
| 52 | 110 | 0.049995 | 118 | 32 | 36.79688 | 236.65625 | null | 5.5 | 0.799927 | 142 | 7.439453 | 251 | 30 | 3,890 | null | 6 | null | 6 |
866 | 62.5 | 1 |
female
| 0 | 4 | 229 |
Lung Cancer
|
Cancer
| 1 | 9 |
under $11k
| 0 | 10,163 | 4,479.3477 | 4,604.37891 | 16 |
white
| 11.898438 | 10 | 0.799927 | 0.574951 | 1 | 0 | 0 |
metastatic
| 0.95 | 0.8 |
no dnr
| 4 | 113 | 6.5 | 80 | 20 | 36 | null | 3.799805 | null | 0.899902 | 138 | null | 194 | 9 | 5,700 | 5 | null |
no(M2 and SIP pres)
| 3.854981 |
867 | 37.47598 | 1 |
male
| 1 | 57 | 57 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 9 |
$11-$25k
| 0 | 270,127 | 120,381.812 | 127,205.188 | 22.75 |
hispanic
| 21.699219 | 26 | 0.911987 | 0.850952 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 57 | 71 | 14.599609 | 55 | 16 | 37.09375 | null | null | 2.599609 | 1.299805 | 131 | null | 99 | 33 | 4,275 | 1 | 0 |
<2 mo. follow-up
| 0 |
868 | 59.45499 | 1 |
female
| 0 | 91 | 205 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 16 |
>$50k
| 0 | 976,623 | 320,064.75 | 374,988.5 | 33 |
white
| 29.199219 | 57 | 0.656982 | 0.55896 | 26 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 91 | 73 | 4.799805 | 115 | 30 | 38.59375 | 312.5 | 4.599609 | 1.599854 | 3.699707 | 142 | 7.379883 | null | 75 | 238 | null | 2 |
adl>=4 (>=5 if sur)
| 2 |
869 | 66.26099 | 1 |
female
| 0 | 7 | 87 |
CHF
|
COPD/CHF/Cirrhosis
| 6 | null | null | 26 | 11,494 | 6,642.3359 | 6,104.63672 | 8.5 |
black
| 13.398438 | 22 | 0.810913 | 0.69397 | 1 | 1 | 0 |
metastatic
| 0.85 | 0.5 |
no dnr
| 7 | 110 | 9.599609 | 109 | 20 | 36 | 442.8125 | 4.599609 | 0.899902 | 1.299805 | 137 | 7.469727 | 251 | 23 | 3,420 | null | null | null | 4.881836 |
870 | 59.03598 | 0 |
male
| 0 | 9 | 1,055 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 20 |
>$50k
| 0 | 21,359 | 10,872.9297 | 11,947.6094 | 19.5 |
white
| 34 | 51 | 0.665894 | 0.491943 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 9 | 49 | 7.099609 | 120 | 16 | 36.39844 | null | null | null | 2.899902 | 132 | null | 100 | 43 | 1,770 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
871 | 60.271 | 1 |
male
| 1 | 55 | 55 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 16 |
$25-$50k
| 0 | 460,668 | 190,896.5 | 216,081.625 | 33.25 |
white
| 20.296875 | 32 | 0.830933 | 0.773926 | 1 | 0 | 0 |
yes
| 0.9 | 0.6 |
dnr after sadm
| 37 | 115 | 7.799805 | 120 | 20 | 36.89844 | null | null | null | 1.699951 | 143 | null | 154 | 85 | 2,850 | null | 3 |
<2 mo. follow-up
| 3 |
872 | 20.99699 | 1 |
male
| 1 | 3 | 3 |
Coma
|
Coma
| 3 | 14 |
under $11k
| 100 | 278,242 | 24,999.6562 | 20,352.4219 | 45 |
asian
| 47.796875 | 92 | 0.003 | 0.001 | 40 | 0 | 0 |
yes
| null | null |
dnr after sadm
| 1 | 60 | 27.5 | 85 | 24 | 35 | 54 | 2.399902 | 20.597656 | 4.099609 | 150 | 6.939453 | 335 | 75 | 110 | null | null |
<2 mo. follow-up
| 3.309082 |
873 | 55.655 | 0 |
female
| 0 | 12 | 1,053 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 26 | 34,920 | 19,289.2969 | 20,270.2656 | 20.5 |
white
| 24.5 | 43 | 0.762939 | 0.687988 | 1 | 0 | 0 |
no
| 0.75 | 0.75 |
no dnr
| 12 | 75 | 8.298828 | 116 | 8 | 36.59375 | 419 | 3.699707 | 0.199982 | 2 | 154 | 7.549805 | 111 | 63 | 2,030 | null | 5 |
adl>=4 (>=5 if sur)
| 5 |
874 | 45.43698 | 0 |
female
| 0 | 93 | 1,053 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 26 | 636,886 | null | null | 40.25 |
white
| 38.398438 | 75 | 0.50293 | 0.385986 | 1 | 0 | 0 |
no
| 0.4 | 0.5 |
no dnr
| 93 | 107 | 0.199982 | 140 | 40 | 37.89844 | 178 | null | 3 | 0.5 | 134 | 7.299805 | null | 23 | 2,050 | null | null | null | 2.833008 |
875 | 49.92499 | 1 |
male
| 0 | 14 | 935 |
Colon Cancer
|
Cancer
| 1 | 17 |
>$50k
| 0 | 23,578 | 12,864.6016 | 14,080.5859 | 7.333332 |
white
| 20.097656 | 18 | 0.802979 | 0.579956 | 1 | 0 | 0 |
metastatic
| 1 | 0.5 |
no dnr
| 14 | 70 | 11.099609 | 120 | 20 | 39.59375 | null | null | null | null | 140 | null | null | null | 3,450 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
876 | 42.11899 | 0 |
female
| 0 | 23 | 1,050 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 16 | null | 26 | 1,086,011 | 48,990.7812 | 62,284.125 | 29 |
hispanic
| 30.097656 | 56 | 0.608887 | 0.50293 | 147 | 0 | 0 |
no
| null | null |
no dnr
| 23 | 72 | 3.899902 | 115 | 28 | 38.19531 | 311.0625 | null | 1.599854 | 2.899902 | 147 | 7.449219 | 78 | 64 | 151 | null | 0 |
no(M2 and SIP pres)
| 0 |
877 | 75.08795 | 1 |
male
| 1 | 4 | 4 |
Coma
|
Coma
| 4 | null | null | 100 | 157,000 | 22,982.7031 | 25,227.9062 | 51 |
white
| 52.09375 | 116 | 0 | 0 | 17 | 1 | 0 |
yes
| null | null |
no dnr
| 4 | 32 | 0.049995 | 155 | 26 | 38.5 | 126.25 | null | null | 4.599609 | 153 | 7.239258 | 67 | 112 | 0 | null | null |
<2 mo. follow-up
| 3.80957 |
878 | 44.32599 | 1 |
male
| 0 | 15 | 526 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 14 |
under $11k
| 0 | 44,950 | 23,775.2188 | 24,613.2969 | 14.333328 |
black
| 32.398438 | 40 | 0.772949 | 0.637939 | 1 | 0 | 0 |
no
| 0.95 | 0.9 |
no dnr
| 15 | 73 | 4.899414 | 95 | 26 | 37.5 | null | 2.099609 | 0.299988 | 2.599609 | 129 | null | 154 | 51 | 2,650 | 0 | 0 |
SIP>=30
| 0 |
879 | 75.17896 | 0 |
male
| 0 | 47 | 1,049 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 15 | null | 26 | 191,750 | 67,892.75 | 66,681.9375 | 28.75 |
white
| 24.5 | 47 | 0.526978 | 0.411987 | 7 | 1 | 0 |
yes
| 0.5 | 0.95 |
no dnr
| 47 | 72 | 8 | 100 | 26 | 37.69531 | 172.5 | null | null | 6.199219 | 142 | 7.449219 | 267 | 78 | 935 | null | 0 | null | 0 |
880 | 51.452 | 1 |
female
| 0 | 6 | 434 |
Lung Cancer
|
Cancer
| 1 | 12 |
$25-$50k
| 0 | 10,606 | 5,724.3086 | 6,900.46875 | 17 |
white
| 15 | 12 | 0.772949 | 0.527954 | 1 | 0 | 0 |
metastatic
| 1 | 0.9 |
no dnr
| 6 | 73 | 3.399902 | 80 | 20 | 36.19531 | null | null | 0.099991 | 0.699951 | 138 | null | null | 8 | 6,150 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
881 | 62.37598 | 1 |
male
| 1 | 14 | 14 |
MOSF w/Malig
|
ARF/MOSF
| 3 | 18 |
>$50k
| 0 | 139,026 | 47,879.5938 | 53,606.2812 | 29.666656 |
black
| 41.695313 | 71 | 0.132996 | 0.060997 | 12 | 0 | 0 |
yes
| 0.5 | 0.25 |
dnr after sadm
| 11 | 108 | 5.399414 | 70 | 12 | 35.89844 | 153.03125 | 2.299805 | 9.599609 | 5.199219 | 127 | 7.419922 | 186 | 101 | 1,131 | null | 4 |
<2 mo. follow-up
| 4 |
882 | 54.47498 | 0 |
male
| 0 | 25 | 1,048 |
Lung Cancer
|
Cancer
| 1 | 16 |
>$50k
| 0 | 94,914 | 44,798.6562 | 55,629.2812 | 15.75 |
white
| 6.299805 | 6 | 0.87793 | 0.723999 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 25 | 97 | 6 | 76 | 20 | 36.19531 | null | 4.099609 | 0.5 | 1.099854 | 138 | null | 165 | 12 | 7,500 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
883 | 52.62997 | 1 |
male
| 0 | 5 | 838 |
Colon Cancer
|
Cancer
| 1 | null | null | 0 | 12,265 | 7,544.2812 | 8,521.5625 | 10 |
white
| 13.099609 | 23 | 0.878906 | 0.726929 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 5 | 101 | 10 | 80 | 22 | 37.79688 | null | 3.799805 | 0.399963 | 1.099854 | 132 | null | 114 | 20 | 1,075 | null | null |
no(M2 and SIP pres)
| 1.857666 |
884 | 75.77496 | 1 |
female
| 0 | 6 | 716 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 13 | null | 0 | 10,782 | 6,787.6914 | 6,076.12891 | 15 |
white
| 17.199219 | 9 | 0.859985 | 0.768921 | 1 | 0 | 0 |
no
| 0.98 | 0.9 |
no dnr
| 6 | 108 | 10.699219 | 95 | 22 | 36.39844 | null | null | null | 0.899902 | 137 | null | null | 15 | 3,450 | 0 | null | null | 0.494751 |
885 | 76.961 | 0 |
female
| 0 | 17 | 1,045 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null |
under $11k
| 0 | 88,755 | 37,615.1875 | 40,109.4375 | 32.333313 |
hispanic
| 28 | 34 | 0.642944 | 0.541992 | 4 | 0 | 0 |
no
| 0.75 | 0.7 |
no dnr
| 17 | 78 | 9.099609 | 105 | 12 | 36.5 | 440 | null | null | 2 | 126 | 7.439453 | 159 | 30 | 7,219 | null | 3 |
adl>=4 (>=5 if sur)
| 3 |
886 | 54.71597 | 0 |
female
| 0 | 10 | 1,045 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 14 |
$25-$50k
| 0 | 31,403 | 15,863.2109 | 15,708.2656 | 20 |
white
| 28.097656 | 53 | 0.782959 | 0.712891 | 1 | 1 | 0 |
no
| 0.3 | 0.25 |
no dnr
| 10 | 100 | 26.296875 | 75 | 15 | 38 | 108.32812 | 2.399902 | 1.399902 | 2.199707 | 132 | 7.369141 | 119 | 56 | 970 | 2 | 2 | null | 2 |
887 | 79.70398 | 1 |
female
| 1 | 11 | 11 |
MOSF w/Malig
|
ARF/MOSF
| 5 | 16 |
$11-$25k
| 0 | 56,752 | 24,689.4531 | 31,170.0625 | 33.5 |
white
| 33.5 | 38 | 0.428955 | 0.309998 | 1 | 1 | 0 |
yes
| 0.5 | 0.3 |
dnr after sadm
| 9 | 60 | 22 | 110 | 36 | 36.09375 | 108 | 2.599609 | null | 0.5 | 135 | 7.459961 | null | 16 | 1,870 | null | null |
<2 mo. follow-up
| 3.677246 |
888 | 53.36099 | 1 |
male
| 1 | 22 | 22 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 18 |
under $11k
| 0 | 314,092 | 84,356.8125 | 90,715.5625 | 36 |
white
| 28.796875 | 40 | 0.724976 | 0.639893 | 7 | 0 | 0 |
no
| null | null |
dnr after sadm
| 22 | 97 | 11.599609 | 70 | 32 | 36.79688 | 313.3125 | 3.099609 | 7.799805 | 2.699707 | 140 | 7.419922 | 286 | 96 | 7,660 | null | 0 |
<2 mo. follow-up
| 0 |
889 | 73.94897 | 1 |
male
| 0 | 28 | 57 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | null | null | 44 | 208,988 | 79,771.75 | 95,195.1875 | 45.25 |
asian
| 31.199219 | 54 | 0.334961 | 0.218994 | 1 | 1 | 0 |
yes
| 0.15 | 0.05 |
dnr after sadm
| 8 | 62 | 6.199219 | 115 | 30 | 38 | 127.5 | null | 0.399963 | 2.699707 | 135 | 7.509766 | 160 | 64 | 5,055 | null | null |
<2 mo. follow-up
| 3.924316 |
890 | 21.20999 | 1 |
male
| 1 | 8 | 8 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | null |
under $11k
| 37 | 73,268 | 28,876.6094 | 37,257.7812 | 27.5 |
hispanic
| 27.097656 | 57 | 0.804932 | 0.73999 | 2 | 0 | 0 |
no
| 0.7 | 0.5 |
no dnr
| 8 | 112 | 7.199219 | 120 | 26 | 38.69531 | 291.375 | 1.599854 | 13.798828 | 0.699951 | 140 | 7.459961 | null | 9 | 1,325 | null | 1 |
<2 mo. follow-up
| 1 |
891 | 86.35199 | 1 |
female
| 1 | 4 | 4 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 |
$11-$25k
| 44 | 125,804 | 11,069.0859 | 12,813.4297 | 31 |
white
| 42.296875 | 70 | 0.028 | 0.007 | 10 | 0 | 0 |
no
| 0.25 | 0.25 |
dnr before sadm
| -3 | 45 | 23.5 | 75 | 36 | 36.19531 | 97 | 2.799805 | null | 2 | 131 | 7.379883 | 310 | 60 | 1,262 | null | 0 |
<2 mo. follow-up
| 0 |
892 | 33.55197 | 1 |
male
| 0 | 6 | 442 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
under $11k
| 0 | 26,882 | 12,281.9531 | 13,067.7891 | 24 |
black
| 23.699219 | 27 | 0.892944 | 0.85498 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 6 | 113 | 15.699219 | 125 | 28 | 39.29688 | 348.5625 | null | null | 1 | 133 | 7.429688 | 69 | 6 | 2,060 | null | null |
no(M2 and SIP pres)
| 3.226563 |
893 | 64.58295 | 1 |
male
| 0 | 5 | 155 |
Lung Cancer
|
Cancer
| 2 | 12 |
$25-$50k
| 0 | 5,751 | 3,211.9102 | 23,493.7031 | 5 |
white
| 13.298828 | 5 | 0.775879 | 0.533936 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 5 | 81 | 5.699219 | 84 | 20 | 37.79688 | null | null | null | 0.799927 | 140 | null | 92 | 11 | 2,775 | null | 0 | null | 0 |
894 | 79.54596 | 1 |
female
| 0 | 5 | 580 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | null | null | 44 | 30,631 | 13,084.1094 | 17,486.9062 | 42 |
white
| 24.398438 | 34 | 0.576904 | 0.465942 | 1 | 1 | 0 |
no
| 0.7 | 0.6 |
no dnr
| 5 | 60 | 15.398438 | 25 | 32 | 38.29688 | null | 3 | null | 0.699951 | 146 | null | 189 | 11 | 422 | null | null | null | 3.564941 |
895 | 67.71497 | 0 |
female
| 0 | 7 | 1,036 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 |
>$50k
| 0 | 46,447 | 10,272.25 | 12,649.1328 | 14.5 |
white
| 23.597656 | 25 | 0.771973 | 0.697998 | 4 | 0 | 0 |
no
| 0.99 | 0.99 |
no dnr
| 7 | 72 | 8.798828 | 72 | 22 | 36.5 | 83.32812 | 2.399902 | 0.699951 | 0.899902 | 133 | 7.539062 | 95 | 11 | 2,050 | 2 | null |
no(M2 and SIP pres)
| 1.838867 |
896 | 48.73599 | 1 |
female
| 0 | 26 | 314 |
Lung Cancer
|
Cancer
| 1 | null | null | 0 | 117,616 | 50,040.3438 | 57,753.0625 | 12 |
white
| 14.5 | 12 | 0.785889 | 0.550903 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 26 | 73 | 5 | 96 | 24 | 37.5 | null | null | 0.199982 | 0.899902 | 135 | null | 88 | 9 | 4,735 | null | null | null | 3.026856 |
897 | 63.79498 | 1 |
female
| 0 | 8 | 68 |
Lung Cancer
|
Cancer
| 1 | 16 |
>$50k
| 0 | 11,253 | 7,390.0273 | 8,001.83984 | 9 |
white
| 11.5 | 13 | 0.803955 | 0.582886 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.6 |
no dnr
| 8 | 101 | 6.399414 | 120 | 24 | 36.19531 | null | 4.199219 | 0.399963 | 0.899902 | 140 | null | 79 | null | 2,200 | 4 | null |
adl>=4 (>=5 if sur)
| 3.183106 |
898 | 88.422 | 1 |
male
| 0 | 17 | 930 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 26 | 111,560 | 36,010.375 | 35,541.2812 | 14.666664 |
white
| 27.199219 | 56 | 0.439941 | 0.320984 | 8 | 0 | 1 |
no
| null | null |
no dnr
| 17 | 72 | 17.199219 | 145 | 36 | 38.69531 | 148.3125 | 2.699707 | 0.399963 | 1.099854 | 146 | 7.479492 | 131 | 21 | 1,975 | null | null | null | 6.273438 |
899 | 54.38199 | 1 |
male
| 1 | 16 | 16 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 13 |
$11-$25k
| 44 | 508,881 | 77,303.1875 | 88,043.3125 | 48 |
white
| 38.398438 | 60 | 0.141998 | 0.066986 | 35 | 0 | 0 |
yes
| 0.7 | 0.7 |
dnr after sadm
| 16 | 117 | 5.099609 | 45 | 27 | 38 | 265 | 3.799805 | 29.5 | 4.899414 | 144 | 7.429688 | 140 | 99 | 619 | null | 2 |
<2 mo. follow-up
| 2 |
900 | 63.62198 | 0 |
male
| 0 | 9 | 1,027 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 14 | null | 0 | 36,522 | 18,165.5312 | 22,120.875 | 22.5 |
white
| 31.597656 | 24 | 0.691895 | 0.525879 | 1 | 0 | 0 |
no
| 0.9 | 0.75 |
no dnr
| 9 | 45 | 12 | 115 | 16 | 36.59375 | null | null | null | 1 | 131 | null | 106 | 16 | 2,960 | 0 | 1 |
no(M2 and SIP pres)
| 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.